Adverse drug events of immune checkpoint inhibitors - a retrospective, descriptive real-world data analysis
Abstract Aims The objective of this study was to analyze immune-related adverse events (irAEs) in a real-world data sample and examine the differences in incidence between affected organ systems, irAE severity, therapeutic agent, and gender. Methods We retrospectively analyzed all consecutive patien...
Saved in:
| Main Authors: | Lauris Annatha Mariam Auch, Chloé Sieber, Dirk Lehnick, Balthasar L. Hug |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14733-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune checkpoint inhibition perturbs neuro-immune homeostasis and impairs cognitive function
by: Onwodi V. Ifejeokwu, et al.
Published: (2025-07-01) -
The comparison of efficacy and safety between cadonilimab (PD-1/CTLA-4) and anti-PD-1 inhibitors in patients with recurrent or metastatic cervical cancer: a retrospective real-world study
by: Baoyue Pan, et al.
Published: (2025-06-01) -
Gene expression and molecular pathway analyses differentiate immunotherapy-induced myositis from spontaneous dermatomyositis
by: Magdalena Röckel, et al.
Published: (2025-08-01) -
A systematic review of gastritis as an immune-related adverse event in clinical interventions
by: Fei Su, et al.
Published: (2024-12-01) -
Cancer therapeutic implications of microRNAs in the regulation of immune checkpoint blockade
by: Yan Zhang, et al.
Published: (2019-08-01)